Wockhardt Stock Price: Soars over 19% after its investigational antibiotic Zaynich successfully treats cancer patient in US
Drugmaker Wockhardt said its investigational antibiotic Zaynich (Zidebactam/Cefepime WCK 5222) was successfully used to treat a cancer patient in the
Continue reading